Effect of Ivabradine on Silent Ambulatory Myocardial Ischemia

Trial Profile

Effect of Ivabradine on Silent Ambulatory Myocardial Ischemia

Completed
Phase of Trial: Phase II

Latest Information Update: 02 Sep 2015

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Coronary artery disease; Ischaemic heart disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 02 Sep 2015 Results presented at the ESC Congress 2015: Annual Congress of the European Society of Cardiology
    • 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
    • 29 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top